ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

1.625
0.025 (1.56%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 1.56% 1.625 1.60 1.65 1.675 1.60 1.60 11,401,604 10:40:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0447 -0.36 1.87M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.60p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 20.75p.

Genedrive currently has 115,139,946 shares in issue. The market capitalisation of Genedrive is £1.87 million. Genedrive has a price to earnings ratio (PE ratio) of -0.36.

Genedrive Share Discussion Threads

Showing 4851 to 4872 of 26350 messages
Chat Pages: Latest  202  201  200  199  198  197  196  195  194  193  192  191  Older
DateSubjectAuthorDiscuss
22/1/2021
11:25
Please don't buy in here bunz. You're a jinx.
hodhasharon
22/1/2021
11:22
part of reason now considering buying here

looking like growing demand for testing globally

also thinking with US likely to increase testing

bunz3
22/1/2021
10:56
find this rise here interesting

is some one building up a holding here while share price this low

or is news expected

will look back in later this afternoon ,or next week

any helpful research would be appreciated

bunz3
22/1/2021
10:42
Do some research
jock3636
22/1/2021
10:37
researching here ,share price looks to have been dropping ,now looks like buyers loading up

interested in hearing why buyers looking to be building up shares here again

why this buying Today

bunz3
22/1/2021
10:35
About bloody time!
yasyas1
22/1/2021
10:32
looking like buying demand building up Today

is news expected

bunz3
22/1/2021
10:14
can any one sell
bunz3
22/1/2021
09:51
Maybe the chap at BGF doesn't want to be the next idiot to slam the company by dumping just before the rerate?
loafofbread
21/1/2021
23:53
Sorry to hear about ur mum dying, heard she went in a bad way
prof_pwhite
21/1/2021
23:52
LOL what a tool
prof_pwhite
21/1/2021
21:48
Just listened to USA news briefing ...Massive amount of money going in to testing facility's ......Dare i say it ..... GDR could multi bag from here !!!Never mind UK about to announce in near term
amaretto1
21/1/2021
21:30
Genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it notified the Food and Drug Association (FDA) in the United States of its intention to import and distribute its Genedrive 96 SARS-CoV-2 Kit prior to an Emergency Use Authorization (EUA) determination, as described in the guidance on Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency, Section IV.C.2.16th Dec 2020
blackvulture
21/1/2021
08:25
But are GDR selling any tests kits in the USA?
pal44
20/1/2021
23:50
Covid live updates: New CDC chief calls for more testing; The U.S. is recording at least 199,700 new Covid-19 cases and at least 2,960 virus-related deaths each day,Biden's new CDC director calls to ramp up Covid testing, vaccinationsThe United States needs to quickly ramp up the amount and pace of Covid-19 testing and vaccinations to bring the current outbreak under control, Dr. Rochelle Walensky said in her first official statement as President Joe Biden's director of the Centers for Disease Control and Prevention."Better, healthier days lie ahead. But to get there, COVID-19 testing, surveillance, and vaccination must accelerate rapidly," Walensky said in a statement. "We must also confront the longstanding public health challenges of social and racial injustice and inequity that have demanded action for far too long."The country will also need to "make up for potentially lost ground in areas like suicide, substance use disorder and overdose, chronic diseases, and global health initiatives," she said.She added that officials will review all current guidance issued by the CDC under the Trump administration and will update it if needed "so that people can make decisions and take action based upon the best available evidence." She placed the CDC's principal deputy director Anne Schuchat in charge of the review process.
blackvulture
20/1/2021
23:25
Will never happen. Hodhashron has confirmed its a fraud
professor_kemche
20/1/2021
22:49
This is true, only if GDR gets its POCT to be approved by the FDA, or equivalent body in the EU.
divmad
20/1/2021
21:30
Point-of-Care Tests Will Make a Breakthrough
“COVID-19 has provided the impetus to develop new, low-cost molecular diagnostic platforms suitable for mass testing such as POCT. According to GlobalData’s pipeline products database, there are over 140 POCT in the pipeline, with over 25 products in approval processes and many likely to see approval in 2021. Companies such as Genedrive are in a great position to introduce large-scale molecular POCT to emerging markets through partnerships.”

mrshaungcm
20/1/2021
20:03
There is no excuse for losses, unless you can't afford a ShareProphets subscription.Sign up and prosper!
professor_hodhasharon
20/1/2021
20:01
big mistake, got 1200 in here!
latifs100
20/1/2021
19:31
i actually bought more today !!
amaretto1
20/1/2021
19:27
Hope so Hod
mrshaungcm
Chat Pages: Latest  202  201  200  199  198  197  196  195  194  193  192  191  Older

Your Recent History

Delayed Upgrade Clock